Click Here for 5% Off Your First Aladdin Purchase!

Ertiprotafib - 98%, high purity , CAS No.251303-04-5

  • ≥98%
Item Number
E649524
Grouped product items
SKUSizeAvailabilityPrice Qty
E649524-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$250.90
E649524-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$420.90
E649524-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$920.90

Basic Description

SynonymsErtiprotafib|251303-04-5|PTP-112|5TPM2EB426|CHEMBL184041|(2R)-2-(4-(9-Bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid|Ertiprotafib [USAN:INN]|UNII-5TPM2EB426|(2R)-2-[4-(9-Bromo-2,3-dimethylnaphtho[2,3-b]thiophen-
Specifications & Purity≥98%
Biochemical and Physiological MechanismsErtiprotafib is an inhibitor of PTP1B, IkB kinase β (IKK-β) , and a dual PPARα and PPARβ agonist, with an IC 50 of 1.6 μM for PTP1B, 400 nM for IKK-β , an EC 50 of ~1 μM for PPARα/PPARβ.
Storage TempStore at 2-8°C,Protected from light,Desiccated
Shipped InWet ice
Product Description

Ertiprotafib is an inhibitor of PTP1B, IkB kinase β (IKK-β) , and a dual PPARα and PPARβ agonist, with an IC 50 of 1.6 μM for PTP1B, 400 nM for IKK-β , an EC 50 of ~1 μM for PPARα/PPARβ.

In Vitro

Ertiprotafib is a potent inhibitor of IKK-β, with an IC 50 value of 400±40 nM, which is much lower than that required for the half-maximal inhibition of the p-nitrophenyl phosphatase activity of PTP1B. The reported IC 50 value of Ertiprotafib against PTP1B ranges from 1.6 to 29 μM depending on the assay conditions. Ertiprotafib is at least a dual PPARα and PPARβ agonist with EC 50 values for transactivation of 1 μM. Such activities readily explain the observations with suprapharmacologic doses of these. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

As seen with treatment of ob/ob mice, both Ertiprotafib and compound 3 seem to significantly improve glucose metabolism in rats. At 25 mg/kg/day, these compounds decrease both fasting blood glucose and insulin levels compared with vehicle treated rats. Furthermore, both Ertiprotafib and compound 3 increase glucose disposal after an oral challenge. It is noteworthy that lipid levels are also reduced in treated animals. Both triglyceride and free fatty acid levels are substantially reduced in rats treated with 25 mg/kg/day of either compound. To summarize, both Ertiprotafib and compound 3 seem to be robust agents in improving glucose utilization in fa/fa rats while also decreasing lipid levels in these animals. Decreased lipid levels may be unexpected for a pure PTP1b inhibitor. It is more telling, as mentioned above, that rats treated with suprapharmacologic doses of Ertiprotafib show signs of PPAR family activation. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal administration

Mice, Rats Male Ob/ob mice and Zucker fa/fa rats are used. They are kept on a 12-h/12-h light/dark cycle and fed Rodent Diet 5001 (for mice and rats) from Purina Mills. Compounds are dosed orally by gavage in an aqueous suspension of 2% Tween 80 and 0.5% methylcellulose. Whole blood (5 μL) is used for glucose readings via tail nick for measurement using the Ascensia Elite XL glucometer and glucose strips by preloading a strip into the meter and touching the end to a small drop of blood on each tail. Insulin levels are quantified by enzyme-linked immunosorbent assay . aladdin has not independently confirmed the accuracy of these methods. They are for reference only.

Form:Solid

IC50& Target:PTP1B|1.6 μM (IC|50|)|IKK-β|400 nM (IC|50|)|PPARα|~1 μM (EC|50|)|PPARβ|~1 μM (EC|50|)

Associated Targets

PTPN1 Tchem Tyrosine-protein phosphatase non-receptor type 1 3 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

IKBKB Tchem Inhibitor of nuclear factor kappa-B kinase subunit beta 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PPARA Tclin Peroxisome proliferator-activated receptor alpha 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PPARG Tclin Peroxisome proliferator-activated receptor gamma 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name (2R)-2-[4-(9-bromo-2,3-dimethylbenzo[f][1]benzothiol-4-yl)-2,6-dimethylphenoxy]-3-phenylpropanoic acid
INCHI InChI=1S/C31H27BrO3S/c1-17-14-22(15-18(2)29(17)35-25(31(33)34)16-21-10-6-5-7-11-21)27-23-12-8-9-13-24(23)28(32)30-26(27)19(3)20(4)36-30/h5-15,25H,16H2,1-4H3,(H,33,34)/t25-/m1/s1
InChi Key FONCZICQWCUXEB-RUZDIDTESA-N
Canonical SMILES CC1=CC(=CC(=C1OC(CC2=CC=CC=C2)C(=O)O)C)C3=C4C(=C(SC4=C(C5=CC=CC=C53)Br)C)C
Isomeric SMILES CC1=CC(=CC(=C1O[C@H](CC2=CC=CC=C2)C(=O)O)C)C3=C4C(=C(SC4=C(C5=CC=CC=C53)Br)C)C
PubChem CID 157049
Molecular Weight 559.51

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

SolubilityDMSO : 100 mg/mL (178.73 mM; Need ultrasonic)

Related Documents

Solution Calculators